Brazil ’s health regulator scraps Bharat Biotech’s EUA application of Covaxin

The move comes after Anvisa was informed by Bharat Biotech that it ’s Brazilian partner-Necessidade no longer has authorization to represent them in Brazil.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news